U.S. markets closed

No Borders, Inc. (NBDR)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.02500.0000 (0.00%)
At close: 3:22PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.0250
Open0.0250
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0200 - 0.0250
52 Week Range0.0001 - 0.0890
Volume164,345
Avg. Volume106,999
Market Cap84,654
Beta (5Y Monthly)-22.43
PE Ratio (TTM)N/A
EPS (TTM)-0.0020
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • No Borders, Inc. (OTC: NBDR) Reports 2020 Annual Financials With Dramatic Year Over Year Revenue Growth
    GlobeNewswire

    No Borders, Inc. (OTC: NBDR) Reports 2020 Annual Financials With Dramatic Year Over Year Revenue Growth

    Mesa, Arizona, April 01, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- No Borders Inc. (OTC: NBDR) (the “Company”) today announces it has filed its Condensed Unaudited Financial & Disclosure Statements with OTC Markets for the full year 2020, reporting its highest gross quarterly and annual revenue since the Company’s merger in 2018. The Company is happy to report massive year over year growth successfully ending 2020 with $8.9M USD in revenue and $1.5M EBITA. Committed to excellence in compliance and disclosure, No Borders is pleased to again complete and submit its quarterly filings on time with OTC Markets. The Company believes shareholder value is best served with consistent right action, and No Borders has built a talented team of professionals who deliver those actions day in and day out. In addition to another strong quarterly performance, the filings demonstrate that No Borders continues to deploy and invest in the brands, operations and technologies it believes are critical to maximizing and increasing shareholder value. The Company’s MediDent Supplies brand has been the main driver of growth in 2020 and with recent investments in needles, syringes and L-108 NIOSH N95s the Company believes it is strongly positioned to deliver scaled volumes of critically needed items to clients big and small across the USA. No Borders has shown its ability to manufacture, transport, import and distribute scaled volumes of physical goods while adhering to stringent FDA, CBP, CDC and other regulatory rules. The Company’s board of directors is confident that the 2020 filings show a tactical deployment of the Company’s talent, capital and relationships with a tangible impact on revenue, EBITA and long term shareholder value. Cynthia Tanabe, COO, stated, “Clearly, this filing shows that the Company is working hard to scale operations while rapidly serving the needs of our clients from coast to coast. I am incredibly proud of our entire team and want to personally thank all of our team members, shareholders, business partners and clients for being a part of this journey with us.” No Borders is proud to share the results of our hard work with our loyal shareholders and the greater market. The Company is deeply focused on completing two years of PCAOB Audits with a goal of filing a Form10 with the SEC and a form 15c-211 with FINRA to reestablish NBDR on the OTC Markets Pink and/or up-listing to the OTCQB Market. While the Company’s Board and Executives have been inundated with the daily work of scaling operations and sales they have also kept a strong focus on vigorously defending NBDR from the egregious actions of Regulators while positioning NBDR to come back to its market as quickly as possible. “It is hard to describe the pride and gratitude I feel looking at the impact our merry band of misfits has accomplished in the past year. I believe our 2020 results speak volumes for our team’s ability to identify opportunities, deploy resources and deliver scaled volumes of goods to clients across America. I am excited to continue this work in 2021 and beyond!” said Joseph Snyder, CEO. About No Borders Inc. No Borders, Inc. (OTC:NBDR) is a multifaceted corporation specializing in the acquisition, creation and scaling of commercial and consumer products by utilizing cutting-edge technologies to reduce costs while increasing revenues and shareholder value across its portfolio of assets. The Company’s portfolio of businesses include: No Borders Dental Resources Inc., a provider of medical equipment, PPE and supplies to medical and dental professionals across the U.S. through the trade name MediDent Supplies (www.MediDentSupplies.com). No Borders Naturals Inc., a purveyor of health and wellness products for active consumers and their pets. (www.NoBordersNaturals.com)No Borders Labs Inc., which provides leading-edge tech tools to NBDR internal companies, while also offering consulting, architecture, hardware and software development services to external businesses looking to update their technology infrastructure for greater efficiency, security and transparency (www.NoBordersLabs.com).www.CBDLabChain.com a No Borders Labs Patent Pending Project; a tool to demonstrate in an unbiased and unchangeable way a clear sense of security to consumers of CBD products by recording Certificate Of Authority (COA) on a blockchain technology platform. No Borders is headquartered in Mesa Arizona. For more information, visit the Company’s website at www.NBDR.co. ON BEHALF OF THE BOARD OF DIRECTORS, Joseph Snyder Chief Executive Officer and Director 7931 E. Pecos Rd. #156 Mesa, AZ 85212 (760) 582-5115 Contact: contact@nbdr.co Source: No Borders, Inc. (NBDR) OTC: NBDR This press release may include certain statements that are forward-looking in nature and that involve a number of uncertainties and risks. Such forward-looking statements are within the meaning of that term in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The forward-looking statements in this press release are based on No Borders, Inc., current expectations and projections regarding future events, which are based on currently available information. The forward-looking statements in this press release may also include statements relating to No Borders, Inc.'s anticipated new developments, business prospects, financial performance, strategies and similar matters. No Borders, Inc. disclaims any obligation to update any of its forward-looking statements, except as may be required by law.

  • Update: No Borders, Inc. Announces Successful Launch of MediDent Supplies Needles and Syringes, with Millions of Needles and Syringes Delivered to Clients Across the USA
    GlobeNewswire

    Update: No Borders, Inc. Announces Successful Launch of MediDent Supplies Needles and Syringes, with Millions of Needles and Syringes Delivered to Clients Across the USA

    MediDent Supplies Disposable Syringes With Needles QUEEN CREEK, AZ, Feb. 23, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- No Borders, Inc. (OTC:NBDR), is proud to announce that the Company’s MediDent Supplies subsidiary has successfully launched its needles and syringes line in an effort to support America's national vaccination efforts. MediDent Supplies began line development and initial production of MediDent Supplies Branded Safety Needles, Syringes, Regular Needles and Needle/Syringe Combo Packs in Q3 2020 with a goal to assist and support the national mission to vaccinate Americans against Covid-19. Initial production was shipped in Q4 2020; those shipments were delivered to State, Hospital and commercial clients across the USA in Q1 2021, rapidly supporting Covid-19 vaccination efforts from coast to coast. MediDent Supplies has ongoing production contracts for MediDent Supplies branded needles and syringes throughout 2021 and 2022. The Company believes that supporting the day to day needs of American healthcare facilities with multiple needle and syringe size variants while bringing in vaccination specific items like 1ml Luer Lok Low Dead Space Syringes, an item that has been in the news recently and may, in many cases, allow for six doses of vaccine per vial instead of five, will provide a large scale, long term revenue stream to the organization. After successfully manufacturing, importing and delivering multiple shipments totaling millions of needles and syringes, MediDent Supplies is proud to have an additional shipment containing millions more needles and syringes that have already cleared customs in Long Beach and close to ten million units already en route from the factory for early March 2021 delivery. The Company will continue to scale production of these critically needed items and has begun accepting six and twelve month production orders from government, healthcare, distributor and commercial clients. MediDent Supplies provides critically needed medical equipment and PPE to organizations, operators, healthcare professionals and civilians around the world. Due to recent events MediDent Supplies has rapidly scaled its supply chains, inventories and distribution capabilities in order to help and serve as rapidly and impactfully as possible. With both on hand inventories as well as production capabilities, MediDent Supplies is committed to serving organizations of any size with the right equipment and PPE at the right time. Joe Snyder, CEO of No Borders, Inc., stated, “Demand for this line has been nothing short of stratospheric and I am so incredibly proud of the impact our team has every single day. Bringing MediDent Supplies Needles and Syringes to our clients at such a critical moment for the national vaccination effort is no small feat. I want to thank Bob, Tina, Cynthia, Chris, Dwight and John, Stefan, Simon, Nick, John and Tony and the entire MediDent Supplies team for the tireless persistence that it takes to make these projects and goals a reality.” "The successful development and deployment of the MediDent Supplies Needles and Syringes line was built with the support and partnership of Guangzhou Harley Commodity Co., Royal Enterprizes LLC and Insight Funding Source LLC, MediDent Supplies is proud to have strong production, manufacturing and financing partnerships that provide our company with a transparent, secure and stable supply of high demand products like L-188 NIOSH N95’s, Needles, Syringes and Nitrile Gloves," stated Cynthia Tanabe, COO of No Borders, Inc. About No Borders Inc. No Borders, Inc. (OTC:NBDR) is a multifaceted corporation specializing in the acquisition, creation and scaling of commercial and consumer products by utilizing cutting-edge technologies to reduce costs while increasing revenues and shareholder value across its portfolio of assets. The Company’s portfolio of businesses include: No Borders Dental Resources Inc., a provider of medical equipment, PPE and supplies to medical and dental professionals across the U.S. through the trade name MediDent Supplies (www.MediDentSupplies.com). No Borders Naturals Inc., a purveyor of health and wellness products for active consumers and their pets. (www.NoBordersNaturals.com) No Borders Labs Inc., which provides leading-edge tech tools to NBDR internal companies while also offering consulting, architecture and software development services to external businesses looking to update their technology infrastructure for greater efficiency, security and transparency (www.NoBordersLabs.com). No Borders is headquartered in Arizona. For more information, visit the Company’s website at www.NBDR.co. ON BEHALF OF THE BOARD OF DIRECTORS, Joseph Snyder Chief Executive Officer and Director 7931 E. Pecos Rd. #156 Mesa, AZ 85212 (760) 582-5115 Contact: contact@nbdr.co Source: No Borders Inc. (NBDR) OTC: NBDR This press release may include certain statements that are forward-looking in nature and that involve a number of uncertainties and risks. Such forward-looking statements are within the meaning of that term in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The forward-looking statements in this press release are based on No Borders, Inc., current expectations and projections regarding future events, which are based on currently available information. The forward-looking statements in this press release may also include statements relating to No Borders, Inc.'s anticipated new developments, business prospects, financial performance, strategies and similar matters. No Borders, Inc. disclaims any obligation to update any of its forward-looking statements, except as may be required by law. Attachment MediDent Supplies

  • No Borders, Inc. Announces Successful Launch of MediDent Supplies Needles and Syringes, with Millions of Needles and Syringes Delivered to Clients Across the USA
    GlobeNewswire

    No Borders, Inc. Announces Successful Launch of MediDent Supplies Needles and Syringes, with Millions of Needles and Syringes Delivered to Clients Across the USA

    QUEEN CREEK, AZ, Feb. 23, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- No Borders, Inc. (OTC:NBDR), is proud to announce that the Company’s MediDent Supplies subsidiary has successfully launched its needles and syringes line in an effort to support America's national vaccination efforts. MediDent Supplies began line development and initial production of MediDent Supplies Branded Safety Needles, Syringes, Regular Needles and Needle/Syringe Combo Packs in Q3 2020 with a goal to assist and support the national mission to vaccinate Americans against Covid-19. Initial production was shipped in Q4 2020; those shipments were delivered to State, Hospital and commercial clients across the USA in Q1 2021, rapidly supporting Covid-19 vaccination efforts from coast to coast. MediDent Supplies has ongoing production contracts for MediDent Supplies branded needles and syringes throughout 2021 and 2022. The Company believes that supporting the day to day needs of American healthcare facilities with multiple needle and syringe size variants while bringing in vaccination specific items like 1ml Luer Lok Low Dead Space Syringes, an item that has been in the news recently and may, in many cases, allow for six doses of vaccine per vial instead of five, will provide a large scale, long term revenue stream to the organization. After successfully manufacturing, importing and delivering multiple shipments totaling millions of needles and syringes, MediDent Supplies is proud to have an additional shipment containing millions more needles and syringes that have already cleared customs in Long Beach and close to ten million units already en route from the factory for early March 2021 delivery. The Company will continue to scale production of these critically needed items and has begun accepting six and twelve month production orders from government, healthcare, distributor and commercial clients. MediDent Supplies provides critically needed medical equipment and PPE to organizations, operators, healthcare professionals and civilians around the world. Due to recent events MediDent Supplies has rapidly scaled its supply chains, inventories and distribution capabilities in order to help and serve as rapidly and impactfully as possible. With both on hand inventories as well as production capabilities, MediDent Supplies is committed to serving organizations of any size with the right equipment and PPE at the right time. Joe Snyder, CEO of No Borders, Inc., stated, “Demand for this line has been nothing short of stratospheric and I am so incredibly proud of the impact our team has every single day. Bringing MediDent Supplies Needles and Syringes to our clients at such a critical moment for the national vaccination effort is no small feat. I want to thank Bob, Tina, Cynthia, Chris, Dwight and John, Stefan, Simon, Nick, John and Tony and the entire MediDent Supplies team for the tireless persistence that it takes to make these projects and goals a reality.” "The successful development and deployment of the MediDent Supplies Needles and Syringes line was built with the support and partnership of Guangzhou Harley Commodity Co., Royal Enterprizes LLC and Insight Funding Source LLC, MediDent Supplies is proud to have strong production, manufacturing and financing partnerships that provide our company with a transparent, secure and stable supply of high demand products like L-188 NIOSH N95’s, Needles, Syringes and Nitrile Gloves," stated Cynthia Tanabe, COO of No Borders, Inc. About No Borders Inc. No Borders, Inc. (OTC:NBDR) is a multifaceted corporation specializing in the acquisition, creation and scaling of commercial and consumer products by utilizing cutting-edge technologies to reduce costs while increasing revenues and shareholder value across its portfolio of assets. The Company’s portfolio of businesses include: No Borders Dental Resources Inc., a provider of medical equipment, PPE and supplies to medical and dental professionals across the U.S. through the trade name MediDent Supplies (www.MediDentSupplies.com). No Borders Naturals Inc., a purveyor of health and wellness products for active consumers and their pets. (www.NoBordersNaturals.com) No Borders Labs Inc., which provides leading-edge tech tools to NBDR internal companies while also offering consulting, architecture and software development services to external businesses looking to update their technology infrastructure for greater efficiency, security and transparency (www.NoBordersLabs.com). No Borders is headquartered in Arizona. For more information, visit the Company’s website at www.NBDR.co. ON BEHALF OF THE BOARD OF DIRECTORS, Joseph Snyder Chief Executive Officer and Director 7931 E. Pecos Rd. #156 Mesa, AZ 85212 (760) 582-5115 Contact: contact@nbdr.co Source: No Borders Inc. (NBDR) OTC: NBDR This press release may include certain statements that are forward-looking in nature and that involve a number of uncertainties and risks. Such forward-looking statements are within the meaning of that term in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The forward-looking statements in this press release are based on No Borders, Inc., current expectations and projections regarding future events, which are based on currently available information. The forward-looking statements in this press release may also include statements relating to No Borders, Inc.'s anticipated new developments, business prospects, financial performance, strategies and similar matters. No Borders, Inc. disclaims any obligation to update any of its forward-looking statements, except as may be required by law.